{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T12:30:39Z","timestamp":1765888239724,"version":"3.48.0"},"reference-count":34,"publisher":"BMJ","issue":"12","license":[{"start":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T00:00:00Z","timestamp":1671494400000},"content-version":"unspecified","delay-in-days":19,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2022,12,6]]},"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Prospectively validate prognostication scores, SOARS and 4C Mortality Score, derived from the COVID-19 first wave, for mortality and safe early discharge in the evolving pandemic with SARS-CoV-2 variants (B.1.1.7 replacing D614) and healthcare responses altering patient demographic and mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Protocol-based prospective observational cohort study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Single site PREDICT and multisite ISARIC (International Severe Acute Respiratory and Emerging Infections Consortium) cohorts in UK COVID-19 second wave, October 2020 to January 2021.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>1383 PREDICT and 20\u2009595 ISARIC SARS-CoV-2 patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Primary outcome measures<\/jats:title>\n                    <jats:p>Relevance of SOARS and 4C Mortality Score determining in-hospital mortality and safe early discharge in the evolving UK COVID-19 second wave.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>1383 (median age 67 years, IQR 52\u201382; mortality 24.7%) PREDICT and 20\u2009595 (mortality 19.4%) ISARIC patient cohorts showed SOARS had area under the curve (AUC) of 0.8 and 0.74, while 4C Mortality Score had AUC of 0.83 and 0.91 for hospital mortality, in the PREDICT and ISARIC cohorts respectively, therefore, effective in evaluating safe discharge and in-hospital mortality. 19.3% (231\/1195, PREDICT cohort) and 16.7% (2550\/14992, ISARIC cohort) with SOARS of 0\u20131 were candidates for safe discharge to a virtual hospital (VH) model. SOARS implementation in the VH pathway resulted in low readmission, 11.8% (27\/229) and low mortality, 0.9% (2\/229). Use to prevent admission is still suboptimal, as 8.1% in the PREDICT cohort and 9.5% in the ISARIC cohort were admitted despite SOARS score of 0\u20131.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>SOARS and 4C Mortality Score remains valid, transforming complex clinical presentations into tangible numbers, aiding objective decision making, despite SARS-CoV-2 variants and healthcare responses altering patient demographic and mortality. Both scores, easily implemented within urgent care pathways for safe early discharge, allocate hospital resources appropriately to the pandemic\u2019s needs while enabling normal healthcare services resumption.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2021-054469","type":"journal-article","created":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T09:57:51Z","timestamp":1671530271000},"page":"e054469","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Relevance of prediction scores derived from the SARS-CoV-2 first wave, in the evolving UK COVID-19 second wave, for safe early discharge and mortality: a PREDICT COVID-19 UK prospective observational cohort study"],"prefix":"10.1136","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0264-3355","authenticated-orcid":false,"given":"Hakim","family":"Ghani","sequence":"first","affiliation":[{"name":"West Hertfordshire Hospitals NHS Trust, Watford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessio","family":"Navarra","sequence":"additional","affiliation":[{"name":"West Hertfordshire Hospitals NHS Trust, Watford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phyoe K","family":"Pyae","sequence":"additional","affiliation":[{"name":"West Hertfordshire Hospitals NHS Trust, Watford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harry","family":"Mitchell","sequence":"additional","affiliation":[{"name":"West Hertfordshire Hospitals NHS Trust, Watford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Evans","sequence":"additional","affiliation":[{"name":"West Hertfordshire Hospitals NHS Trust, Watford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rigers","family":"Cama","sequence":"additional","affiliation":[{"name":"West Hertfordshire Hospitals NHS Trust, Watford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Shaw","sequence":"additional","affiliation":[{"name":"West Hertfordshire Hospitals NHS Trust, Watford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben","family":"Critchlow","sequence":"additional","affiliation":[{"name":"West Hertfordshire Hospitals NHS Trust, Watford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tejal","family":"Vaghela","sequence":"additional","affiliation":[{"name":"West Hertfordshire Hospitals NHS Trust, Watford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"Schechter","sequence":"additional","affiliation":[{"name":"West Hertfordshire Hospitals NHS Trust, Watford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nazril","family":"Nordin","sequence":"additional","affiliation":[{"name":"West Hertfordshire Hospitals NHS Trust, Watford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Barlow","sequence":"additional","affiliation":[{"name":"West Hertfordshire Hospitals NHS Trust, Watford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rama","family":"Vancheeswaran","sequence":"additional","affiliation":[{"name":"West Hertfordshire Hospitals NHS Trust, Watford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2022,12,20]]},"reference":[{"key":"2025121604263253000_12.12.e054469.1","unstructured":"World Health Organization . COVID-19 significantly impacts health services for noncommunicable diseases. Available: https:\/\/www.who.int\/news\/item\/01-06-2020-covid-19-significantly-impacts-health-services-for-noncommunicable-diseases"},{"key":"2025121604263253000_12.12.e054469.2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2020-003675"},{"key":"2025121604263253000_12.12.e054469.3","doi-asserted-by":"crossref","first-page":"e1372","DOI":"10.1016\/S2214-109X(20)30383-1","article-title":"Projected health-care resource needs for an effective response to COVID-19 in 73 low-income and middle-income countries: a modelling study","volume":"8","author":"Tan-Torres Edejer","year":"2020","journal-title":"Lancet Glob Health"},{"key":"2025121604263253000_12.12.e054469.4","unstructured":"United Nation . World\u2019s most vulnerable countries lack the capacity to respond to a global pandemic. Available: https:\/\/www.un.org\/ohrlls\/news\/world%E2%80%99s-most-vulnerable-countries-lack-capacity-respond-global-pandemic-credit-mfdelyas-alwazir"},{"key":"2025121604263253000_12.12.e054469.5","unstructured":"World Health Organization . Coronavirus (COVID-19) Dashboard. Available: https:\/\/covid19.who.int\/"},{"key":"2025121604263253000_12.12.e054469.6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/d41586-021-01390-4","article-title":"What scientists know about new, fast-spreading coronavirus variants","volume":"594","author":"Adam","year":"2021","journal-title":"Nature"},{"key":"2025121604263253000_12.12.e054469.7","doi-asserted-by":"publisher","DOI":"10.1038\/d41586-021-00121-z"},{"key":"2025121604263253000_12.12.e054469.8","doi-asserted-by":"crossref","first-page":"90","DOI":"10.12788\/jhm.3552","article-title":"Trends in COVID-19 risk-adjusted mortality rates","volume":"16","author":"Horwitz","year":"2021","journal-title":"J Hosp Med"},{"key":"2025121604263253000_12.12.e054469.9","doi-asserted-by":"crossref","unstructured":"Jassat W , Mudara C , Ozougwu L . Increased mortality among individuals hospitalised with COVID-19 during the second wave in South Africa. MedRxiv 2021.doi:10.1101\/2021.03.09.21253184","DOI":"10.1101\/2021.03.09.21253184"},{"key":"2025121604263253000_12.12.e054469.10","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1080\/23744235.2021.1884745","article-title":"Lombardy, Northern Italy: COVID-19\u2009second wave less severe and deadly than the first? A preliminary investigation","volume":"53","author":"Borghesi","year":"2021","journal-title":"Infect Dis"},{"key":"2025121604263253000_12.12.e054469.11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0248029"},{"key":"2025121604263253000_12.12.e054469.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2021.110856"},{"key":"2025121604263253000_12.12.e054469.13","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jinf.2020.10.033","article-title":"First and second COVID-19 waves in Japan: a comparison of disease severity and characteristics","volume":"82","author":"Saito","year":"2021","journal-title":"J Infect"},{"key":"2025121604263253000_12.12.e054469.14","doi-asserted-by":"publisher","DOI":"10.1111\/tbed.13819"},{"key":"2025121604263253000_12.12.e054469.15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n1124"},{"key":"2025121604263253000_12.12.e054469.16","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/S1473-3099(21)00170-5","article-title":"Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a whole-genome sequencing and hospital-based cohort study","volume":"21","author":"Frampton","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"2025121604263253000_12.12.e054469.17","doi-asserted-by":"crossref","unstructured":"Snell LB , Wang W , Alcolea-Medina A . First and second SARS-CoV-2 waves in inner London: a comparison of admission characteristics and the impact of the B.1.1.7 variant. MedRxiv 2021.03.16.21253377 2021 March.","DOI":"10.1101\/2021.03.16.21253377"},{"key":"2025121604263253000_12.12.e054469.18","unstructured":"Gov.uk . Coronovirus (COVID-19) in the UK. Cases in United Kingdom. Available: https:\/\/coronavirus.data.gov.uk\/details\/cases"},{"key":"2025121604263253000_12.12.e054469.19","doi-asserted-by":"crossref","unstructured":"Tegally H , Wilkinson E , Giovanetti M . Emergence and rapid spread of a new severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) lineage with multiple spike mutations in South Africa. MedRxiv 2020;10.doi:10.1101\/2020.12.21.20248640","DOI":"10.1101\/2020.12.21.20248640"},{"key":"2025121604263253000_12.12.e054469.20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19808-4"},{"key":"2025121604263253000_12.12.e054469.21","doi-asserted-by":"crossref","unstructured":"Jensen N , Kelly AH , Avendano M . The COVID-19 pandemic underscores the need for an equity-focused global health agenda. Humanit Soc Sci Commun 2021;8.doi:10.1057\/s41599-020-00700-x","DOI":"10.1057\/s41599-020-00700-x"},{"key":"2025121604263253000_12.12.e054469.22","unstructured":"World Health Organization . Timeline: WHO\u2019s COVID-19 response. Available: https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/interactive-timeline#event-229"},{"key":"2025121604263253000_12.12.e054469.23","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.03498-2020"},{"key":"2025121604263253000_12.12.e054469.24","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m3339"},{"key":"2025121604263253000_12.12.e054469.25","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2020-216425"},{"key":"2025121604263253000_12.12.e054469.26","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(20)30461-6","article-title":"The changing demographics of COVID-19","volume":"8","author":"Venkatesan","year":"2020","journal-title":"Lancet Respir Med"},{"key":"2025121604263253000_12.12.e054469.27","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-045356"},{"key":"2025121604263253000_12.12.e054469.28","unstructured":"The National Institute for Health and Care Excellence . COVID-19 rapid guideline: managing COVID-19. Available: https:\/\/www.nice.org.uk\/guidance\/ng191\/chapter\/Recommendations"},{"key":"2025121604263253000_12.12.e054469.29","unstructured":"European Centre for Disease Prevention and Control . Weekly COVID-19 country overview. Available: https:\/\/covid19-country-overviews.ecdc.europa.eu\/#2_Global"},{"key":"2025121604263253000_12.12.e054469.30","unstructured":"Centers for Disease Control and Prevention . Science brief: COVID-19 vaccines and vaccination. Available: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/science\/science-briefs\/fully-vaccinated-people.html"},{"key":"2025121604263253000_12.12.e054469.31","doi-asserted-by":"publisher","DOI":"10.1016\/S2589-7500(21)00017-0"},{"key":"2025121604263253000_12.12.e054469.32","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m4074"},{"key":"2025121604263253000_12.12.e054469.33","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/S0140-6736(21)01018-7","article-title":"COVID-19 vaccine impact in Israel and a way out of the pandemic","volume":"397","author":"Leshem","year":"2021","journal-title":"Lancet"},{"key":"2025121604263253000_12.12.e054469.34","doi-asserted-by":"publisher","DOI":"10.7326\/M20-4076"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2021-054469","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T12:26:44Z","timestamp":1765888004000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2021-054469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":34,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,12,20]]},"published-print":{"date-parts":[[2022,12]]}},"alternative-id":["10.1136\/bmjopen-2021-054469"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2021-054469","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"type":"print","value":"2044-6055"},{"type":"electronic","value":"2044-6055"}],"subject":[],"published":{"date-parts":[[2022,12]]}}}